By Louis P. Berneman, Todd C. Davis, D. Patrick O’Reilley and Matthew Raymond
Louis P. Berneman, EdD, CLP, RTTP
Texelerate, LLC
Todd C. Davis
HealthCare Royalty Partners
D. Patrick O'Reilley
Finnegan
Matthew J. Raymond, PhD
Rush University Medical Center
Biopharmaceutical companies and not-for-profit (academic) research institutions have become increasingly adept at structuring license and related collaboration agreements. In recent years, there has been a gradual increase in research collaborations, co-promotion and marketing agreements and royalty monetizations.
Full articles are available only to LESI Members. Please login to view the PDF of this Les Nouvelles Article.
Not an LESI member? Find out how to join your regional LES society and gain access to all that your LES society and LESI has to offer.